Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria

INTRODUCTION: Tigecycline is an established treatment option for infections with multiresistant bacteria (MRB). It retains activity against many strains with limited susceptibility to other antibiotics. Efficacy and safety of tigecycline as monotherapy or in combination regimens were investigated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Heizmann, W. R., Löschmann, P.-A., Eckmann, C., von Eiff, C., Bodmann, K.-F., Petrik, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315528/
https://www.ncbi.nlm.nih.gov/pubmed/25367409
http://dx.doi.org/10.1007/s15010-014-0691-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315528/
https://www.ncbi.nlm.nih.gov/pubmed/25367409
http://dx.doi.org/10.1007/s15010-014-0691-4

Ejemplares similares